OPPENHEIMER & CO INC TRVI — TREVI THERAPEUTICS INC

Ownership history in OPPENHEIMER & CO INC  ·  9 quarters on record

AI Ownership Summary

OPPENHEIMER & CO INC reported TREVI THERAPEUTICS INC (TRVI) in 9 quarterly 13F filings from 2024 Q1 through 2026 Q1. Peak portfolio weight reached 0.02% in 2025 Q4. The latest visible filing shows TRVI at 0.01% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings.

What this TRVI ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was OPPENHEIMER & CO INC's position in TREVI THERAPEUTICS INC, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2026 Q1

TRVI was reported at 0.01% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
0.02% in 2025 Q4

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2024 Q1 to 2026 Q1

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

TRVI stock page OPPENHEIMER & CO INC fund profile OPPENHEIMER & CO INC full holdings
How OPPENHEIMER & CO INC held TRVI — position size vs. price
% of Fund (quarterly)    TRVI price (quarter-end, indexed to 100)    SPY (indexed to 100)    QQQ (indexed to 100)
📋 Quarterly Holdings History 9 quarters  ▾
Quarter Action Sold % After 3M Timing Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2026 Q1 REDUCED — — — 100,027 -671 -0.7% 0.01% $1.2M 2026-04-24 $14.41
2025 Q4 ADDED — — — 100,698 +2,030 +2.1% 0.02% $1.3M 2026-02-02 $10.96
2025 Q3 REDUCED — — — 98,668 -1,157 -1.2% 0.01% $903K 2025-11-06 $11.01
2025 Q2 REDUCED — — — 99,825 -612 -0.6% 0.01% $546K 2025-07-31 $7.41
2025 Q1 ADDED — — — 100,437 +19,034 +23.4% 0.01% $632K 2025-04-23 $6.27
2024 Q4 REDUCED — — — 81,403 -544 -0.7% 0.01% $335K 2025-02-05 $4.21
2024 Q3 ADDED — — — 81,947 +21,128 +34.7% 0.00% $274K 2024-11-05 $3.02
2024 Q2 ADDED — — — 60,819 +404 +0.7% 0.00% $181K 2024-08-08 $2.80
2024 Q1 INITIATED — — — 60,415 — — 0.00% $208K 2024-05-07 $2.90

🏢 Other funds also holding TRVI

As of 2026 Q1 — sorted by position size

PFS Partners, LLC 0.43% PSP Research LLC 0.25% PEREGRINE CAPITAL MANAGEMENT LLC 3Y 7Y 0.23% TRUST CO OF TOLEDO NA /OH/ 3Y 7Y 0.15% CHAPIN DAVIS, INC. 3Y 0.05% Maltin Wealth Management, Inc. 3Y 0.05% Hilton Head Capital Partners, LLC 0.03% Pictet Asset Management Holding SA 0.02% NBC SECURITIES, INC. 0.02% Diversified Trust Co 3Y 7Y 0.01%

FAQ About OPPENHEIMER & CO INC and TRVI

These are the practical questions this page is built to answer before you even open the full history table.

How long has OPPENHEIMER & CO INC reported owning TRVI?

OPPENHEIMER & CO INC reported TRVI across 9 quarterly 13F filings, from 2024 Q1 through 2026 Q1.

What was the largest reported TRVI position in OPPENHEIMER & CO INC's portfolio?

The largest reported portfolio weight for TRVI was 0.02% in 2025 Q4.

What is the latest reported TRVI position on this page?

The most recent filing on this page is 2026 Q1, when OPPENHEIMER & CO INC reported 100,027 shares, equal to 0.01% of portfolio, with an estimated market value of $1.2M.

What does the chart on this TRVI ownership page compare?

The chart compares OPPENHEIMER & CO INC's quarterly TRVI portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

How well did OPPENHEIMER & CO INC time their TRVI position?

Based on 13F filing dates vs. subsequent TRVI price moves, OPPENHEIMER & CO INC correctly timed 5 out of 8 reported position changes (62%). The annualised alpha on TRVI relative to SPY over the holding period was +76.6%.

← Back to OPPENHEIMER & CO INC Holdings